Chargement en cours...
Design innovations and baseline findings in a long-term Parkinson’s trial: NET-PD LS-1
BACKGROUND: Based on the pre-clinical and the results of a phase 2 futility study, creatine was selected for an efficacy trial in Parkinson’s disease (PD). We present the design rationale and a description of the study cohort at baseline. METHODS: A randomized, multicenter, double-blind, parallel gr...
Enregistré dans:
| Format: | Artigo |
|---|---|
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3481179/ https://ncbi.nlm.nih.gov/pubmed/23079770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.25175 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|